Enterprise Value
0.00
Cash
0.00
Avg Qtr Burn
N/A
Short % of Float
0.00%
Insider Ownership
0.08%
Institutional Own.
77.31%
Qtr Updated
12/31/23
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Mycapssa (octreotide) Details Acromegaly | Approved Quarterly sales | |
Juxtapid/Lojuxta (lomitapide) Details HoFH (Homozygous Familial Hypercholesterolemia) | Approved Quarterly sales | |
Myalept (metreleptin injections) Details GL (Generalized Lipodystrophy) | Approved Quarterly sales |